1. Home
  2. NTRA vs PAYX Comparison

NTRA vs PAYX Comparison

Compare NTRA & PAYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$208.72

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Logo Paychex Inc.

PAYX

Paychex Inc.

HOLD

Current Price

$93.95

Market Cap

36.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
PAYX
Founded
2003
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
36.8B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
PAYX
Price
$208.72
$93.95
Analyst Decision
Strong Buy
Hold
Analyst Count
14
13
Target Price
$253.79
$126.85
AVG Volume (30 Days)
1.1M
4.1M
Earning Date
02-27-2026
03-25-2026
Dividend Yield
N/A
4.67%
EPS Growth
N/A
N/A
EPS
N/A
4.42
Revenue
$2,116,676,000.00
$6,033,900,000.00
Revenue This Year
$33.95
$19.05
Revenue Next Year
$16.72
$5.89
P/E Ratio
N/A
$20.92
Revenue Growth
38.17
12.37
52 Week Low
$125.38
$91.70
52 Week High
$256.36
$161.24

Technical Indicators

Market Signals
Indicator
NTRA
PAYX
Relative Strength Index (RSI) 35.85 24.79
Support Level $203.86 $91.70
Resistance Level $213.96 $99.56
Average True Range (ATR) 8.54 2.69
MACD -2.07 -0.66
Stochastic Oscillator 23.88 11.97

Price Performance

Historical Comparison
NTRA
PAYX

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About PAYX Paychex Inc.

Paychex is a technology company providing human capital management solutions, enabling clients to better implement payroll, talent, time, tax, and benefits administration. It has a diverse set of product offerings addressing client needs. Aside from its traditional cloud-based payroll and HCM software offering, which accounts for close to half of total revenue, the company provides outsourcing options. Paychex's administrative service organization and professional employer organization accounts generate over 40% of sales. The balance of revenue is generated through retirement services, insurance solutions, and other products. In fiscal 2025, the company had 800,000 clients and almost 2.5 million worksite employees across its ASO and PEO.

Share on Social Networks: